273 related articles for article (PubMed ID: 15286015)
1. Poliovirus vaccination during pregnancy, maternal seroconversion to simian virus 40, and risk of childhood cancer.
Engels EA; Chen J; Viscidi RP; Shah KV; Daniel RW; Chatterjee N; Klebanoff MA
Am J Epidemiol; 2004 Aug; 160(4):306-16. PubMed ID: 15286015
[TBL] [Abstract][Full Text] [Related]
2. Is there a role for SV40 in human cancer?
Poulin DL; DeCaprio JA
J Clin Oncol; 2006 Sep; 24(26):4356-65. PubMed ID: 16963733
[TBL] [Abstract][Full Text] [Related]
3. Case-control study of cancer among US Army veterans exposed to simian virus 40-contaminated adenovirus vaccine.
Rollison DE; Page WF; Crawford H; Gridley G; Wacholder S; Martin J; Miller R; Engels EA
Am J Epidemiol; 2004 Aug; 160(4):317-24. PubMed ID: 15286016
[TBL] [Abstract][Full Text] [Related]
4. Polio vaccines, Simian Virus 40, and human cancer: the epidemiologic evidence for a causal association.
Dang-Tan T; Mahmud SM; Puntoni R; Franco EL
Oncogene; 2004 Aug; 23(38):6535-40. PubMed ID: 15322523
[TBL] [Abstract][Full Text] [Related]
5. Case-control study of simian virus 40 and non-Hodgkin lymphoma in the United States.
Engels EA; Viscidi RP; Galloway DA; Carter JJ; Cerhan JR; Davis S; Cozen W; Severson RK; de Sanjose S; Colt JS; Hartge P
J Natl Cancer Inst; 2004 Sep; 96(18):1368-74. PubMed ID: 15367569
[TBL] [Abstract][Full Text] [Related]
6. Thirty-five year mortality following receipt of SV40- contaminated polio vaccine during the neonatal period.
Carroll-Pankhurst C; Engels EA; Strickler HD; Goedert JJ; Wagner J; Mortimer EA
Br J Cancer; 2001 Nov; 85(9):1295-7. PubMed ID: 11720463
[TBL] [Abstract][Full Text] [Related]
7. Antibody responses to simian virus 40 T antigen: a case-control study of non-Hodgkin lymphoma.
Engels EA; Chen J; Hartge P; Cerhan JR; Davis S; Severson RK; Cozen W; Viscidi RP
Cancer Epidemiol Biomarkers Prev; 2005 Feb; 14(2):521-4. PubMed ID: 15734981
[TBL] [Abstract][Full Text] [Related]
8. Cancer incidence in Denmark following exposure to poliovirus vaccine contaminated with simian virus 40.
Engels EA; Katki HA; Nielsen NM; Winther JF; Hjalgrim H; Gjerris F; Rosenberg PS; Frisch M
J Natl Cancer Inst; 2003 Apr; 95(7):532-9. PubMed ID: 12671021
[TBL] [Abstract][Full Text] [Related]
9. Serum antibodies to JC virus, BK virus, simian virus 40, and the risk of incident adult astrocytic brain tumors.
Rollison DE; Helzlsouer KJ; Alberg AJ; Hoffman S; Hou J; Daniel R; Shah KV; Major EO
Cancer Epidemiol Biomarkers Prev; 2003 May; 12(5):460-3. PubMed ID: 12750243
[TBL] [Abstract][Full Text] [Related]
10. Cancer risk associated with receipt of vaccines contaminated with simian virus 40: epidemiologic research.
Engels EA
Expert Rev Vaccines; 2005 Apr; 4(2):197-206. PubMed ID: 15889993
[TBL] [Abstract][Full Text] [Related]
11. Maternal exposure to herpes simplex virus and risk of psychosis among adult offspring.
Buka SL; Cannon TD; Torrey EF; Yolken RH;
Biol Psychiatry; 2008 Apr; 63(8):809-15. PubMed ID: 17981263
[TBL] [Abstract][Full Text] [Related]
12. Potential exposure to SV40 in polio vaccines used in Sweden during 1957: no impact on cancer incidence rates 1960 to 1993.
Olin P; Giesecke J
Dev Biol Stand; 1998; 94():227-33. PubMed ID: 9776244
[TBL] [Abstract][Full Text] [Related]
13. Markers of past infection with simian virus 40 (SV40) and risk of incident non-Hodgkin lymphoma in a Maryland cohort.
Rollison DE; Helzlsouer KJ; Halsey NA; Shah KV; Viscidi RP
Cancer Epidemiol Biomarkers Prev; 2005 Jun; 14(6):1448-52. PubMed ID: 15941954
[TBL] [Abstract][Full Text] [Related]
14. Population-based study of antibody to the human polyomaviruses BKV and JCV and the simian polyomavirus SV40.
Knowles WA; Pipkin P; Andrews N; Vyse A; Minor P; Brown DW; Miller E
J Med Virol; 2003 Sep; 71(1):115-23. PubMed ID: 12858417
[TBL] [Abstract][Full Text] [Related]
15. Lack of serologic evidence for prevalent simian virus 40 infection in humans.
Carter JJ; Madeleine MM; Wipf GC; Garcea RL; Pipkin PA; Minor PD; Galloway DA
J Natl Cancer Inst; 2003 Oct; 95(20):1522-30. PubMed ID: 14559874
[TBL] [Abstract][Full Text] [Related]
16. Polyomavirus SV40 infections in Kazakhstan.
Nurgalieva ZZ; Wong C; Zhangabylov AK; Omarbekova ZE; Graham DY; Vilchez RA; Butel JS
J Infect; 2005 Feb; 50(2):142-8. PubMed ID: 15667916
[TBL] [Abstract][Full Text] [Related]
17. Antibodies to SV40 in sera from humans and macaques.
Minor P; Pipkin PA
Dev Biol (Basel); 2006; 123():99-107; discussion 119-32. PubMed ID: 16566439
[No Abstract] [Full Text] [Related]
18. Frequency of antibody to BK antigen in women whose children developed malignancies and women who developed detectable carcinoma in situ of the cervix during this pregnancy.
Madden DL; Iltis J; Tzan N; Sever JL
Prog Clin Biol Res; 1983; 105():149-56. PubMed ID: 6304751
[TBL] [Abstract][Full Text] [Related]
19. Population immunity to polioviruses among preschool children from four urban underserved low income communities, United States, 1997-2001.
Prevots DR; Pascual FB; Angellili ML; Brayden R; Irigoyen M; Larussa P; Sawyer M; Baughman AL; Pallansch MA
Pediatr Infect Dis J; 2004 Dec; 23(12):1130-6. PubMed ID: 15626951
[TBL] [Abstract][Full Text] [Related]
20. Simian virus 40 (SV40) and human cancer: a review of the serological data.
Shah KV; Galloway DA; Knowles WA; Viscidi RP
Rev Med Virol; 2004; 14(4):231-9. PubMed ID: 15248251
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
